carole sable  revolution medicines  zoominfocom scynexis appoints carole sable md as chief medical officer nasdaqscyx facebook google linkedin twitter email rss feb   previous release  next release pdf add to briefcase file is in briefcase scynexis appoints carole sable md as chief medical officer research triangle park nc feb   — drug discovery company scynexis inc today announced that it has appointed infectious disease expert carole sable md as chief medical officer dr sable was most recently a vice president at merck  co inc initially as franchise integrator in infectious diseases and more recently as vp project leadership and management in neurosciences and ophthalmology “carole brings to scynexis a significant tenure in the clinical development of infectious disease products both as a clinician and in various corporate roles” said dr yves ribeill scynexis president and chief executive officer “we look forward to her contributions as we continue to advance our lead candidate scy a novel oral and intravenous antifungal compound as well as our antiviral platform” “scy represents a promising potential alternative for patients with invasive fungal infections who still experience significant morbidity and mortality despite antifungal treatment with currently available antifungal agents” commented dr sable “i am thrilled to be a part of scynexis’ experienced and dedicated team as we look to bring novel antiinfectives to patients in need” prior to her recent involvement with merck  co dr sable served as chief medical officer of novexel sa and president of novexel inc the us subsidiary where she was responsible for clinical development and successfully filed two inds and successfully completed phase b studies for two antibacterial programs which led to the acquisition of novexel sa by astrazeneca previously dr sable was executive director of infectious disease and vaccines clinical research at merck  co inc where she was responsible for antibacterial antifungal and vaccine development programs including the clinical development of the antifungal agent cancidas® while with merck dr sable also supervised the development and regulatory submissions for invanz® and the inlicensing of the antiinfective aminomethylcycline ptk from paratek pharmaceuticals as well as programs for sepsis malaria and anthrax dr sable began her career as an assistant professor of medicine and infectious diseases at the university of virginia in charlottesville she received an md from jefferson medical college in  and completed an internal medicine residency and infectious disease fellowship at the university of virginia about scynexis scynexis is a pharmaceutical company committed to the discovery development and commercialization of novel antiinfectives to address significant unmet therapeutic needs we are developing our lead product candidate scy as a novel oral and intravenous iv drug for the treatment of serious and lifethreatening invasive fungal infections in humans in addition we have clinical and preclinical programs based on the use of cyclophilin inhibitors to treat viral diseases as well as contract research and development services primarily in the field of animal health wwwscynexiscom company amanda mancuso – chief of staff scynexis inc amandamancusoscynexiscom tel  99   media relations cory tromblee – macdougall biomedical communications ctrombleemacbiocomcom tel  7   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext7 about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext7 personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext7 legal privacy  cookies  7 microsoft carol sable  west bloomfield  mi  company information products resources my account talk to a db advisor  business directory mi west bloomfield business services nec business services at noncommercial site carol sable c carol sable claim this business  fairview ct west bloomfield mi  get directions  9 business info founded  incorporated annual revenue  employee count  industries business services at noncommercial site contacts carol sable contact business your email address subject message send message company summary since  the company has been providing business services at noncommercial site verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   c view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocal7com mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc 7 all rights reserved sable carole a md in charlottesville va 9  chamberofcommercecom  sign up sign in contact us   search   near   home » virginia » charlottesville » general practice » sable carole a md sable carole a md  reviews  stars  based on  reviews charlottesville virginia 9  99     print  save  directions about sable carole a md is located at the address in charlottesville virginia 9 they can be contacted via phone at  99 for pricing hours and directions sable carole a md specializes in plastic surgery sprains  strains diabetes sable carole a md provides consultations plastic surgery in home care to its customers for maps and directions to sable carole a md view the map to the right for reviews of sable carole a md see below business features products arch supports  astigmatic contacts  childrens eyewear  supplements  nutritional supplements  therapeutic shoes  orthotics  pillows  light  thin lenses  metal services in home care  plastic surgery  referrals  consultations  eyewear fittings  counseling  hair removal  health  wellness treatments  family planning  spider vein treatments specialties nail disorders  diabetes  headaches  sprains  strains  sciatica  disc problems  eczema  skin allergies  plastic surgery  orthotics   information contact information phone  99 phone  97 categories general practice health care physicians people also viewed muller william h jr md charlottesville virginia 9 dane joseph r phd 77 hydraulic rd charlottesville virginia 9 shipley patricia md 9 e jefferson st ste  charlottesville virginia 9 caraway david md phd 9 e jefferson st charlottesville virginia 9 kuhlmann thomas p md facep stoney pt charlottesville virginia 9 mccallum richard w md  tally ho dr charlottesville virginia 9 reviews add you must sign in to post reviews by on click here to be the first to review this business  reviews     site map faq privacy policy terms of use about partners chamber partner program chamber member benefits top cities atlanta bronx brooklyn chicago cleveland dallas denver detroit houston las vegas los angeles miami minneapolis new york philadelphia phoenix saint louis san antonio san diego san jose  7 chamberofcommercecom vitae pharmaceuticals announces appointment of carole sable md as chief medical officer nasdaqvtae english français register sign in vitae pharmaceuticals announces appointment of carole sable md as chief medical officer june    et  source vitae pharmaceuticals inc fort washington pa june   globe newswire  vitae pharmaceuticals inc nasdaqvtae a clinicalstage biotechnology company today announced that carole sable md has been named chief medical officer effective immediately dr sable will oversee the clinical development of vitae’s pipeline including wholly owned midstage clinical assets vtp7 an oral roryt inhibitor being developed for autoimmune disorders and currently being assessed in moderate to severe psoriasis and vtp a topical lxrβ selective agonist being studied in mild to moderate atopic dermatitis“we are pleased to welcome carole to the vitae team as our chief medical officer” said jeff hatfield president and chief executive officer of vitae “carole has a demonstrated track record of success in leading clinical development efforts in multiple therapeutic areas from discovery through nda filing this broad clinical expertise will be invaluable to vitae as we continue advancing and expanding our pipeline of novel therapies for difficulttodrug targets with high unmet medical need”dr sable brings to vitae more than  years of diverse clinical development and executive management experience having been involved in all phases of clinical research including the filing of several new drug applications with the us food and drug administration as well as multiple worldwide marketing applications she most recently served as chief medical officer of revolution medicines inc prior to revolution medicines dr sable served as chief medical officer at scynexis inc in this role she was responsible for all clinical development clinical pharmacology and regulatory activities earlier in her career dr sable has held several senior positions at merck  co inc where she oversaw preparation of the new drug application for belsorma® leading to its approval in  dr sable also served as chief medical officer of novexel sa where she led worldwide clinical development activities until the company’s acquisition by astrazeneca in  additionally she has authored nearly  scientific reviews and articles“i look forward to supporting the advancement of vitae’s potential firstinclass therapies for patients with autoimmune disorders and atopic dermatitis who are underserved by currently marketed treatments” said dr sabledr sable earned her md at jefferson medical college of thomas jefferson university and subsequently completed her internship and residency in internal medicine at the university of virginia hospital she then completed a fellowship in infectious diseases at the university of virginia health sciences centerabout vitae pharmaceuticals vitae pharmaceuticals is a clinicalstage biotechnology company developing firstinclass product candidates with potential to transform the treatment paradigm for patients with significant unmet medical needs initial indications being pursued include psoriasis other autoimmune disorders and atopic dermatitis vitae’s lead clinical assets include vtp7 an oral roryt inhibitor currently being studied in patients with moderate to severe psoriasis and vtp an lxrβ selective agonist being studied in patients with mild to moderate atopic dermatitisfor additional information please visit the companys website at wwwvitaepharmacomsafe harbor statementthis release contains forwardlooking statements within the meaning of section e of the securities exchange act of 9 as amended including but not limited to the development of vitae’s clinical programs these forwardlooking statements are subject to a number of risks including the risk factors set forth from time to time in vitae’s sec filings including but not limited to the risks that are described in the “risk factors” and “management’s discussion and analysis of financial condition and results of operations” sections of vitae’s annual report on form k for the year ended december   and quarterly report on form q for the quarter ended march   which are on file with the sec and available on the sec’s website at wwwsecgov in addition to the risks described above and in vitae’s other filings with the sec other unknown or unpredictable factors also could affect vitae’s results no forwardlooking statements can be guaranteed and actual results may differ materially from such statements the information in this release is provided only as of the date of this release and vitae undertakes no obligation to update any forwardlooking statements contained in this release on account of new information future events or otherwise except as required by lawinvestors vitae pharmaceuticals inc richard s morris cpa chief financial officer   rmorrisvitaerxcom westwicke partners john woolford   johnwoolfordwestwickecom media  degrees pr tony plohoros 9 99 tplohorosdegreesprcom related articles other press releases by vitae pharmaceuticals inc vitae pharmaceuticals to present at wells fargo healthcare conference september    vitae pharmaceuticals to present at wedbush pacgrow healthcare conference august   7 vitae pharmaceuticals appoints scott applebaum as general counsel and corporate secretary august    vitae pharmaceuticals reports second quarter  operating and financial results august    vitae pharmaceuticals to announce second quarter  financial results on august   august   7 7 other news releases in directors and officers in the last  days profile vitae pharmaceuticals inc   subscribe via rss  subscribe via atom  javascript fort washington pennsylvania united states contact data investors vitae pharmaceuticals inc richard s morris cpa chief financial officer   rmorrisvitaerxcom westwicke partners john woolford   johnwoolfordwestwickecom media  degrees pr tony plohoros 9 99 tplohorosdegreesprcom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files vitae pharmaceuticals inc logo logo url  copy the link below formats available original medium small newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca 9 phone  77 fax  77 european headquarters woolgate exchange  basinghall street london ecv ha uk phone    7 globenewswire inc all rights reserved fluid foundation  sable sand  carole franck   9  find a storefree shipping on all orders above login  sign upwishlisthomeshopfeatured itemsproductsrollon sculptoval9 9shop by categorycleaners  tonersmasks  exfoliatorstreatment oilsmoisturisersserumseye areashop by categorysun protectionbody caremensmakeupsalon size productsgift packagesblogabout usshipping  returnsprivacy policycontact  fluid foundation – sable sand 9 9 categories makeup mineral foundations sku  7 availability in stock add to basket add to wishlist remove from wishlist share this description reviews  product description color sablesand benefits fluid foundation ultra fine easy to apply longlasting and without transfer unifies and revives the complexion leaves a natural file that beautifies the face ingredients the exclusive complex enriched with plants vitamins iris evening primrose germ oil and palm oil preserves the youth of the face smoothes the face’s features controls the light and neutralizes the harmful effects of uv be the first to review “fluid foundation – sable sand” cancel replyyou must be logged in to post a comment reviews there are no reviews yet related products  lip care mango golden tube gr add to basketquick view add to wishlist remove from wishlist    lip care cherry – golden tube gr add to basketquick view add to wishlist remove from wishlist    lip care rose – golden tube gr add to basketquick view add to wishlist remove from wishlist   fluid foundation – beige clair  light beige add to basketquick view add to wishlist remove from wishlist 9 mineral powder – transluscent g add to basketquick view add to wishlist remove from wishlist 9  fluid foundation – ivoire ivory add to basketquick view add to wishlist remove from wishlist 9 9  lip care naturel – golden tube gr add to basketquick view add to wishlist remove from wishlist    lip care beige – golden tube gr add to basketquick view add to wishlist remove from wishlist